Trials / Unknown
UnknownNCT06339541
The ACC Preclinical Research Platform for Precision Oncology
La Piattaforma ACC di Ricerca Preclinica Per l'Oncologia di Precisione
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Fondazione del Piemonte per l'Oncologia · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
The ACC Preclinical Research Platform for Precision Oncology is a retrospective and prospective observational study focused on the implementation and validation of the application of PDCM (Patient Derived Cancer Models) generated from tissues or cells of patients with neoplastic disease, as a tool to improve molecular and biological knowledge of tumours and to test the efficacy and sensitivity of pharmacological treatments.
Detailed description
This is a retrospective and prospective observational study, focused on the implementation and validation of the application of PDCM, generated from tissue or cells of patients, including paediatric patients, with solid and haematological malignancies, as a tool to improve molecular and biological knowledge of tumours and to test the efficacy and sensitivity of pharmacological treatments. An up-to-date database of all PDCMs available at the participating italian hospitals will be generated and enriched with new models generated during the course of the project. The sharing of models and procedures between the different hospitals will facilitate their molecular and phenotypic characterisation, also in parallel with the tumours of origin, as well as their validation as tools for testing the efficacy of drugs for precision medicine. By establishing common workflows and standards and performing cross-validation experiments it is planned to build a network of reference centres as a resource for drug screening on 2D and 3D models.
Conditions
Timeline
- Start date
- 2023-06-05
- Primary completion
- 2024-06-01
- Completion
- 2024-12-01
- First posted
- 2024-04-01
- Last updated
- 2024-04-01
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06339541. Inclusion in this directory is not an endorsement.